Cannabigerol (CBG) or Cannabigerolic Acid (CBGA)
Before considering any medicine or treatment that contains cannabinoid to treat the illness, it is useful to learn the effects of that cannabinoid profile. Use of lab testing has rapidly become an industry standard because it has proved to be an exceptional tool. A number of chemists allow the patients to count the cannabinoids breakdown in their existing medicine. This trend has led to an overwhelming interest in the cannabinoids “the minor one”. THC or Tetrahydrocannabinol, due to its natural properties of treating different diseases, was in the focus of breeder for decades until numerous medical advantages of cannabidiol (CBD) began being published. Discoveries similar to these drove an interest in CBG, and also for the cannabinoids that are derived from the plant.
An ability to produce CBGA is what turns that ordinary plane, a unique one. CBGA is said to be the precursor to the few major divisions of cannabinoids: THCA or tetrahydrocannabinol acid, CBDA or cannabidiolic acid, and CBCA. Synthases is a natural enzyme that is found naturally in the cannabis plant and is helpful in breaking the cannabigerolic acid and mold it toward the branch that is desired. The synthases of the cannabis plant (CBD-synthase, CBC-synthase, THC-synthase) are named for the cannabinoid they assist creating.
When prolonged UV light or heat is applied to cannabinoid acids, they lose a CO2 molecule. At this point, they are measured to be in its actual form (THC, CBG, CBC, CBD, and so on). In numerous medicinal strains, cannabinoid acids turn immediately to another cannabinoid and are typically found in low concentrations. However, if the strain is high, then vaping it by smoking will cause it to change into CBG (cannabigerol).
As compare to the industrial hemp strains which test much higher, normally numerous cannabis strands are 10% or less. They have been tested with over 94% in the whole CBG with as low as 0.001% THC. Industrial Hemp’s testing has concluded the level of CBG high as compared to few other strains of cannabis’. Due to this result, further studies took place and found that this phenomenon might be because of a recessive gene. This recessive gene is believed to be accountable for keeping the cannabis plant from producing synthases marijuana stock listing.
As supported by many studies, breeders are capable to manipulate the cannabinoid profile of a plant by making an adjustment in the natural production of each synthase. If, for some reasons, a breeder needs to put an emphasis on a particular cannabinoid they can do it by cross-breeding genetically predisposed plants to make it. However, for CBG, the breeder would focus on the plants with the gene instead, that inhibits an ability of cannabis extract, cannabinoid synthase. A new head breeder, Odie Deisel, at TGA genetics Subcool Seeds has assisted in producing a cannabigerol (CBG) strain with high levels. According to their official online portal, Mickey Kush is a strain that sativa dominant and it is a result of Jack the Ripper and Sweet Irish Kush.
The studies/research for cannabigerol along with its effects are very limited because of the restrictions on cannabis as it belongs to Schedule 1-Narcotics category, and due to that, it is quite hard to carry on a research on a product that is legally banned in the country. However, the number of research that has been done it is concluded that Cannabigerol (CBG) can work with numerous other cannabis extracts such as CBD and THC to provide balance as well as overall synergy.
Due to such results cannabigerol has been classified as an antagonist for CB1-receptor, which can directly affect the CNS (central nervous system) and because of this, cannabigerol is believed to counteract the paranoid, partially “heady” high usually linked with THC. Cannabigerol has also been determined in affecting the CB2-receptor, which ultimately influences the body even more.
Another effect CBG has on the brain is that it obstructs the uptake of a brain chemical, GABA, that regulates the stimulation needed by a neuron to cause a reaction. With the inhibition of GABA, anxiety and muscle tension decreases, resembling the effect of CBG. Another study that took place in Italy and published in Biological Psychology affirms that CBG has strong properties against inflammation and might benefit patients who are suffering from IBD. It is also assisting in treating other various diseases such as glaucoma.
Cannabigerol (CBG) Deserves More Attention
Cannabigerol assists the brain in finding a happy medium between other cannabinoids, causing an emotion of synergy. It is also the primary acid which acts as an initial requirement in the cannabinoid’s development, and it also has a few additional advantages when smoked. As researchers have found many uses of CBGA, Odie Diesel thought to pay more attention so that new medicinal strains can be discovered to help patients.